Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
NW Angel Fund is a Seattle-based venture capital and angel investment firm that focuses on early-stage companies in the Pacific Northwest. The fund invests across several high-growth sectors, with a significant emphasis on life sciences, healthcare, and biotechnology, alongside information technology and consumer products. Managed by Nathan and Brianna McDonald, the firm provides strategic capital, mentorship, and syndication support to help startups scale from seed to later stages. NW Angel Fund operates as a catalyst for the Ecosystem Venture Group and maintains a robust network of accredited investors and industry experts to drive innovation and impact. Notable healthcare-related investments in its portfolio include companies such as Combat Medical, Mussel Polymers, and PredxBio.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on NW Angel Fund.